Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?
finance.yahoo.com
29.08.2026 00:26
9 views
Similar stories
1 outlet
A Major $12.9 Billion Catalyst Is Brewing for Nvidia Stock
finance.yahoo.com
30.08.2026
Related stories
Nvidia’s stock is climbing as investors get more confidence in an expanding base of AI customers
marketwatch.com · 02.09
How Oracle’s ‘extremely controversial’ stock could more than double from here
marketwatch.com · 02.09
How GoPro went from viral camera sensation to a victim of smartphone ubiquity
marketwatch.com · 02.09
Broadcom’s stock falls despite upbeat earnings, extending a frustrating stretch for investors
marketwatch.com · 02.09
JPMorgan curbed lending to Jane Street as trading firm muscled into bonds
ft.com · 02.09
HPE follows in Dell’s footsteps as it rides the AI server boom to a big earnings beat
marketwatch.com · 02.09